11 |
Therapeutic Targeting of BMP and TGF-β Signalling Pathways for the Resolution of Pulmonary Arterial HypertensionSharmin, Nahid January 2018 (has links)
Vascular remodelling due to excessive proliferation and apoptosis resistance of
pulmonary arterial smooth muscle (PASMCs) and endothelial cells (ECs) has
been attributed to the pathogenesis of pulmonary arterial hypertension (PAH). It
is an incurable cardiovascular disorder, which leads to right heart failure and
death, if left untreated. Heterozygous germline mutations in the bone
morphogenetic protein receptor type II (BMPR2) have been linked with the
majority (~75%) of the familial form of the disease (HPAH). Mutations in the
BMPR2 gene impinge upon the BMP signalling which perturbs the balance
between BMP and TGF-β pathways leading to the clinical course of the disease.
Current therapies were discovered prior to the knowledge that PAH has
substantial genetic components. Hence, this study aims to identify novel
therapeutic intervention and provide novel insights into how the dysfunctional
BMPRII signalling contributes to the pathogenesis of PAH. This work
demonstrates that cryptolepines and FDA approved drugs (doxorubicin, taxol,
digitoxin and podophyllotoxin) inhibit the excessive proliferation and induce
apoptosis in BMPR2 mutant PASMCs by modulating the BMP and TGF-β
pathways. Moreover, established drug PTC124 has also been tested but has
failed to promote translational readthrough. I have also shown that dysregulated
apoptosis of PASMCs and HPAECs is mediated through the BMPRII-ALK1-BclxL
axis. Finally, the siRNA screen targeting approximately 1000 genes has
identified novel proteins including PPP1CA, IGF-1R, MPP1, MCM5 and SRC
each capable of modulating the BMPRII signalling. Taken together, this study for
the very first time has identified novel compounds with pro-BMP and anti-TGFβ
activities which may provide therapeutic intervention prior to or after the onset of
PAH. / Commonwealth Scholarship Commission in the UK
|
12 |
Echocardiography for the noninvasive study of the pulmonary circulation: applications to the study of right ventricular effects of targeted therapies of pulmonary hypertension, limiting factors to exercise capacity, and detection of early pulmonary vascular disease in healthy subjects / Apport de l'échocardiographie dans l'étude non invasive de la circulation pulmonaire: (1) étude pharmacologique, (2) étude des facteurs limitant l'aptitude aérobie, (3) étude sur l'identification de l'hypertension artérielle pulmonaire latentePavelescu, Adriana 08 October 2012 (has links)
Ce travail a été consacré à l’étude non invasive de la circulation pulmonaire normale par mise en œuvre de l’échocardiographie Doppler. <p>En intégrant les mesures obtenues dans une approche physiopathologique, et en exploitant les nouvelles possibilités d’échocardiographes portables, techniquement performants, nous avons analysé les effets d’un inhibiteur de la phosphodiestérase-5 et d’une prostacycline, pour tenter d’en identifier d’éventuels effets introtropes intrinsèques, nous avons exploré le concept de réserve vasculaire pulmonaire comme facteur limitant de l’aptitude aérobie et indice potentiel d’une atteinte vasculaire pulmonaire précoce, et obtenu des résultats préliminaires permettant d’identifier une hypertension artérielle pulmonaire (HTAP) latente. Nos principaux résultats peuvent être résumés comme suit :<p>1. Chez le sujet sain, en normoxie ou dans un modèle expérimental d’HTAP induite par l’inhalation d’un mélange gazeux hypoxique, le sildenafil per os ou l’epoprostenol par voie intraveineuse, à des doses utilisées en clinique pour le traitement de l’HTAP, améliorent les indices de la fonction ventriculaire droite en proportion de leurs effets vasodilatatoires pulmonaires, sans effets inotropes intrinsèques détectables.<p>2. La consommation d’oxygène maximale du sujet sain augmente en raison directe de son volume capillaire pulmonaire (calculé à partir de sa capacité de diffusion pour l’oxyde nitrique et le monoxyde de carbone) et en raison inverse de sa résistance vasculaire pulmonaire, non seulement en altitude, mais aussi au niveau de la mer. Ce résultat suggère qu’une plus grande réserve vasculaire pulmonaire est propice aux efforts aérobiques intenses, probablement par moindre postcharge ventriculaire droite.<p>3. Des mesures réalisées chez un petit nombre de sujets suggèrent que la distensibilité vasculaire pulmonaire, calculée à partir d’une relation débit-pression vasculaire pulmonaire, est typiquement réduite chez des porteurs asymptomatiques de la mutation BMPR2, qui est actuellement le facteur de risque le plus élevé connu de l’HTAP. La mutation BMPR2 pourrait aussi être associée à une réactivité vasculaire pulmonaire accrue à l’hypoxie. <p>Nos résultats suggèrent indirectement que l’échocardiographie Doppler, de repos ou de stress, pourrait être davantage développée dans la mise au point de patients à risque d’HTAP./<p><p>Novel advances in echocardiography offer the opportunity to reliably characterize pulmonary circulation in terms of pressure-flow relationship, and to better understand the coupling of right ventricular (RV) function with normal and abnormal pulmonary hemodynamics. Moreover, when combined with the measurement of pulmonary capillary blood volume, this renewed methodological approach may help to understand the concept of pulmonary vascular reserve as a limiting factor of exercise capacity and potential sensitive marker of early vascular disease.<p><p>In the present work we used a model of hypoxic pulmonary vasoconstriction to analyse the effects of two targeted therapies of pulmonary arterial hypertension (PAH) on the RV function. We showed that the beneficial effects of these drugs are mainly driven by a decrease in RV afterload and not an enhanced myocardial inotropic state. Whether this is transposable to abnormal RV-arterial coupling in PAH patients remains to be investigated.<p><p>Echocardiography may be useful to explore the pulmonary vascular reserve as an important limiting factor of exercise capacity. We showed that a higher pulmonary vascular reserve, defined by a decreased PVR and increased lung diffusing capacity, allows for an improved aerobic exercise capacity (as assessed by a higher peak oxygen consumption), at a lower ventilatory cost, at sea level and at high altitude. <p><p>Stress echocardiography may detect an abnormal pulmonary vasoreactivity. We showed that asymptomatic relatives of patients suffering from idiopathic pulmonary arterial hypertension, and who carry a bone morphogenetic protein receptor type 2 mutation (BMPR2) present with a decreased pulmonary vascular distensibility and an enhanced pulmonary vasoreactivity to hypoxia, which are identifiable by echocardiography examination. However, the predictive value of these findings is not known. <p><p>Thus echocardiography may represent, in experienced and dedicated hands, a noninvasive, safe, widely available, applicable at the bed-side as well as in extreme environment (e.g. high altitudes), less expensive alternative for the evaluation of the pulmonary circulation, either by the interrogation of pressure-flow relationship (stress echocardiography), by the investigation of the right ventricle global and regional function in relation to its afterload (standard and Tissue Doppler Imaging), or by a combined approach with the measurement of lung diffusing capacity (DLNO / DLCO) to assess the pulmonary vascular reserve.<p><p>The present data are encouraging for further development and implementation of echocardiography for the detection, but also the diagnosis and follow-up of patients with pulmonary hypertension.<p><p> / Doctorat en Sciences médicales / info:eu-repo/semantics/nonPublished
|
13 |
Pathobiologie de la hernie diaphragmatique congénitale expérimentale induite par l'exposition au nitrofène chez le rat / Pathobiology of experimental congenital diaphragmatic hernia induced by nitrofen in ratMakanga, Martine 29 April 2015 (has links)
Doctorat en Sciences biomédicales et pharmaceutiques / info:eu-repo/semantics/nonPublished
|
Page generated in 0.0323 seconds